Advertisement

The Gut-Brain Connection and Its Significance to Gastroenterologists

  • W. Harley Sobin
Chapter

Abstract

Some patients with more severe disorders of gut-brain interaction (DGBI) will fail to improve with gut-directed therapies and dietary change. Some of them will require use of central neuromodulators, and many will benefit from psychological therapies. The importance of a biopsychosocial model for functional gastrointestinal disorders is discussed. The significance of anxiety, depression, and early life trauma in determining the severity of functional GI disorders is reviewed. The incidence of psychiatric abnormalities in patients with IBS and other FGIDs is examined. The benefit of different psychological therapies for managing DBGIs is evaluated.

Keywords

Disorders of gut-brain interaction (DGBI) Functional gastrointestinal disorders (FGID) Central neuromodulators Irritable bowel syndrome (IBS) Anxiety Depression Cognitive behavioral therapy (CBT) 

References

  1. 1.
    Engel GL. The need for a new medical model: a challenge for biomedicine. Science. 1977;196:129.  https://doi.org/10.1126/science.847460.CrossRefGoogle Scholar
  2. 2.
    Drossman DA. Presidential address: gastrointestinal illness and the biopsychosocial model. Psychosom Med. 1998;60:258.  https://doi.org/10.1097/00006842-199805000-00007.CrossRefPubMedGoogle Scholar
  3. 3.
    Tanaka Y, Kanazawa M, Fukudo S, Drossman DA. Biopsychosocial model of irritable bowel syndrome. J Neurogastroenterol Motil. 2011;17(2):131–9.  https://doi.org/10.5056/jnm.2011.17.2.131.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Bennett EJ, Tennant CC, Piesse C, Badcock CA, Kellow JE. Level of chronic life stress predicts clinical outcome in irritable bowel syndrome. Gut. 1998;43:256.  https://doi.org/10.1136/gut.43.2.256.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Walker LS, Garber J, Smith CA, Van Slyke DA, Claar RL. The relation of daily stressors to somatic and emotional symptoms in children with and without recurrent abdominal pain. J Consult Clin Psychol. 2001;69:85.  https://doi.org/10.1037/0022-006X.69.1.85.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Mayer EA. The neurobiology of stress and gastrointestinal disease. Gut. 2000;47:861.  https://doi.org/10.1136/gut.47.6.861.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Ford MJ, Miller PM, Eastwood J, Eastwood MA. Life events, psychiatric illness and the irritable bowel syndrome. Gut. 1987;28:160.  https://doi.org/10.1136/gut.28.2.160.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Creed F, Guthrie E. Psychological factors in the irritable bowel syndrome. Gut. 1987;28:1307.  https://doi.org/10.1136/gut.28.10.1307.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Toner BB, Garfinkel PE, Jeejeebhoy KN. Psychological factors in irritable bowel syndrome. Can J Psychiatr. 1990;35:158.CrossRefGoogle Scholar
  10. 10.
    Osterberg E, Blomquist L, Krakau I, Weinryb RM, Asberg M, Hultcrantz R. A population study on irritable bowel syndrome and mental health. Scand J Gastroenterol. 2000;35(3):264–8.CrossRefGoogle Scholar
  11. 11.
    Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology. 2002;122:1140.  https://doi.org/10.1053/gast.2002.32392.CrossRefPubMedGoogle Scholar
  12. 12.
    Lydiard RB. Irritable bowel syndrome, anxiety, and depression: what are the links? J Clin Psychiatry. 2001;62(Suppl 8):38–45; discussion 46–7. http://www.ncbi.nlm.nih.gov/pubmed/12108820. Accessed 28 Aug 2016.PubMedGoogle Scholar
  13. 13.
    Lee S, Wu J, Ma YL, Tsang A, Guo W-J, Sung J. Research article: irritable bowel syndrome is strongly associated with generalized anxiety disorder: a community study. Aliment Pharmacol Ther. 2009;30:643.  https://doi.org/10.1111/j.1365-2036.2009.04074.x.CrossRefPubMedGoogle Scholar
  14. 14.
    Drossman DA, Leserman J, Nachman G, et al. Sexual and physical abuse in women with functional or organic gastrointestinal disorders. Ann Intern Med. 1990;113(11):828–33.CrossRefGoogle Scholar
  15. 15.
    Leserman J, Drossman DA, Li Z, Toomey TC, Nachman G, Glogau L. Sexual and physical abuse history in gastroenterology practice: how types of abuse impact health status. Psychosom Med. 1996;58:4.  https://doi.org/10.1097/00006842-199601000-00002.CrossRefPubMedGoogle Scholar
  16. 16.
    Drossman DA. Abuse, trauma, and GI illness: is there a link. Am J Gastroenterol. 2011;106:14.  https://doi.org/10.1038/ajg.2010.453.CrossRefPubMedGoogle Scholar
  17. 17.
    Walker EA, Katon WJ, Roy-Byrne PP, Jemelka RP, Russo J. Histories of sexual victimization in patients with irritable bowel syndrome or inflammatory bowel disease. Am J Psychiatry. 1993;150:1502.  https://doi.org/10.1176/ajp.150.10.1502.CrossRefPubMedGoogle Scholar
  18. 18.
    Lackner JM, Brasel AM, Quigley BM, et al. The ties that bind: perceived social support, stress, and IBS in severely affected patients. Neurogastroenterol Motil. 2010;22:893.  https://doi.org/10.1111/j.1365-2982.2010.01516.x.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Drossman DA, Whitehead WE, Toner BB, et al. What determines severity among patients with painful functional bowel disorders? Am J Gastroenterol. 2000;95:974.  https://doi.org/10.1016/S0002-9270(00)00728-0.CrossRefPubMedGoogle Scholar
  20. 20.
    Van Oudenhove L, Levy RL, Crowell MD, et al. Biopsychosocial aspects of functional gastrointestinal disorders: how central and environmental processes contribute to the development and expression of functional gastrointestinal disorders. Gastroenterology. 2016;150(6):1355–1367e2.  https://doi.org/10.1053/j.gastro.2016.02.027.CrossRefGoogle Scholar
  21. 21.
    Neal KR, Barker L, Spiller RC. Prognosis in post-infective irritable bowel syndrome: a six year follow up study. Gut. 2002;51:410.  https://doi.org/10.1136/gut.51.3.410.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Levy RL, Whitehead WE, Walker LS, et al. Increased somatic complaints and health-care utilization in children: effects of parent IBS status and parent response to gastrointestinal symptoms. Am J Gastroenterol. 2004;99:2442.  https://doi.org/10.1111/j.1572-0241.2004.40478.x.CrossRefPubMedGoogle Scholar
  23. 23.
    Drossman DA. Redux: do little bellyachers grow up to become big bellyachers? Clin Gastroenterol Hepatol. 2014;12:2033.  https://doi.org/10.1016/j.cgh.2014.06.009.CrossRefPubMedGoogle Scholar
  24. 24.
    Drossman DA, Leserman J, Li Z, Keefe F, Hu YJ, Toomey TC. Effects of coping on health outcome among women with gastrointestinal disorders. Psychosom Med. 2000;62:309.  https://doi.org/10.1097/00006842-200005000-00004.CrossRefPubMedGoogle Scholar
  25. 25.
    Drossman DA, McKee DC, Sandler RS, et al. Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology. 1988;95(3):701–8.CrossRefGoogle Scholar
  26. 26.
    Young SJ, Alpers DH, Norland CC, Woodruff RA. Psychiatric illness and the irritable bowel syndrome. Practical implications for the primary physician. Gastroenterology. 1976;70(2):162–6.CrossRefGoogle Scholar
  27. 27.
    Sperber AD, Drossman DA. Review article: the functional abdominal pain syndrome. Aliment Pharmacol Ther. 2011;33(5):514–24.  https://doi.org/10.1111/j.1365-2036.2010.04561.x.CrossRefGoogle Scholar
  28. 28.
    Törnblom H, Drossman DA. Centrally targeted pharmacotherapy for chronic abdominal pain. Neurogastroenterol Motil. 2015;27(4):455–67.  https://doi.org/10.1111/nmo.12509.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Mayer EA, Tillisch K. The brain-gut axis in abdominal pain syndromes. Annu Rev Med. 2011;62:381–96.  https://doi.org/10.1146/annurev-med-012309-103958.CrossRefGoogle Scholar
  30. 30.
    Drossman DA, Ringel Y, Vogt BA, et al. Alterations of brain activity associated with resolution of emotional distress and pain in a case of severe irritable bowel syndrome. Gastroenterology. 2003;124:754.  https://doi.org/10.1053/gast.2003.50103.CrossRefPubMedGoogle Scholar
  31. 31.
    Seminowicz DA, Labus JS, Bueller JA, et al. Regional gray matter density changes in brains of patients with irritable bowel syndrome. Gastroenterology. 2010;139(1):48–57.e2.  https://doi.org/10.1053/j.gastro.2010.03.049.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Jones MP, Dilley JB, Drossman D, Crowell MD. Brain-gut connections in functional GI disorders: anatomic and physiologic relationships. Neurogastroenterol Motil. 2006;18:91.  https://doi.org/10.1111/j.1365-2982.2005.00730.x.CrossRefPubMedGoogle Scholar
  33. 33.
    Dekel R, Drossman DA, Sperber AD. The use of psychotropic drugs in irritable bowel syndrome. Expert Opin Investig Drugs. 2013;22(3):329–39.  https://doi.org/10.1517/13543784.2013.761205.CrossRefGoogle Scholar
  34. 34.
    Dorn SD, Palsson OS, Thiwan SIM, et al. Increased colonic pain sensitivity in irritable bowel syndrome is the result of an increased tendency to report pain rather than increased neurosensory sensitivity. Gut. 2007;56(9):1202–9.  https://doi.org/10.1136/gut.2006.117390.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Clouse RE, Lustman PJ. Use of psychopharmacological agents for functional gastrointestinal disorders. Gut. 2005;54(9):1332–41.  https://doi.org/10.1136/gut.2004.048884.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Lackner JM, Ma CX, Keefer L, et al. Type, rather than number, of mental and physical comorbidities increases the severity of symptoms in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2013;11:1147.  https://doi.org/10.1016/j.cgh.2013.03.011.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Sperber AD, Dekel R. Irritable bowel syndrome and co-morbid gastrointestinal and extra-gastrointestinal functional syndromes. J Neurogastroenterol Motil. 2010;16:113.  https://doi.org/10.5056/jnm.2010.16.2.113.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Ford AC, Quigley EMM, Lacy BE, et al. Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol. 2014;109(9):1350–65; quiz 1366.  https://doi.org/10.1038/ajg.2014.148.CrossRefPubMedGoogle Scholar
  39. 39.
    Lackner JM, Mesmer C, Morley S, Dowzer C, Hamilton S. Psychological treatments for irritable bowel syndrome: a systematic review and meta-analysis. J Consult Clin Psychol. 2004;72:1100.  https://doi.org/10.1037/0022-006X.72.6.1100.CrossRefPubMedGoogle Scholar
  40. 40.
    Lydiard RB, Greenwald S, Weissman MM, Johnson J, Drossman DA, Ballenger JC. Panic disorder and gastrointestinal symptoms: findings from the NIMH Epidemiologic Catchment Area project. Am J Psychiatry. 1994;151:64.  https://doi.org/10.1176/ajp.151.1.64.CrossRefPubMedGoogle Scholar
  41. 41.
    Spiegel BMR, Khanna D, Bolus R, Agarwal N, Khanna P, Chang L. Understanding gastrointestinal distress: a framework for clinical practice. Am J Gastroenterol. 2011;106:380.  https://doi.org/10.1038/ajg.2010.383.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Levy RL, Langer SL, Walker LS, et al. Cognitive-behavioral therapy for children with functional abdominal pain and their parents decreases pain and other symptoms. Am J Gastroenterol. 2010;105:946.  https://doi.org/10.1038/ajg.2010.106.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Toner BB, Segal ZV, Emmott S, et al. Cognitive-behavioral group therapy for patients with irritable bowel syndrome. Int J Group Psychother. 1998;48:215.CrossRefGoogle Scholar
  44. 44.
    Hunt MG. Reclaim your life from IBS. New York: Sterling; 2016.Google Scholar
  45. 45.
    Keefer L. Extinguishing fear of gastrointestinal symptoms to treat functional gastrointestinal disorders. Clin Gastroenterol Hepatol. 2016;14:1559.  https://doi.org/10.1016/j.cgh.2016.07.004.CrossRefPubMedGoogle Scholar
  46. 46.
    Bremner JD. Does stress damage the brain. Biol Psychiatry. 1999;45:797.  https://doi.org/10.1016/S0006-3223(99)00009-8.CrossRefPubMedGoogle Scholar
  47. 47.
    Perera TD, Park S, Nemirovskaya Y. Cognitive role of neurogenesis in depression and antidepressant treatment. Neuroscientist. 2008;14:326.  https://doi.org/10.1177/1073858408317242.CrossRefPubMedGoogle Scholar
  48. 48.
    Brunoni AR, Lopes M, Fregni F. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int J Neuropsychopharmacol. 2008;11(8):1169–80.  https://doi.org/10.1017/S1461145708009309.CrossRefPubMedGoogle Scholar
  49. 49.
    Blankstein U, Chen J, Diamant NE, Davis KD. Altered brain structure in irritable bowel syndrome: potential contributions of pre-existing and disease-driven factors. Gastroenterology. 2010;138(5):1783–9.  https://doi.org/10.1053/j.gastro.2009.12.043.CrossRefPubMedGoogle Scholar
  50. 50.
    Mayer EA, Brunnhuber S. Gastrointestinal disorders. Handb Clin Neurol. 2012;106:607–31.  https://doi.org/10.1016/B978-0-444-52002-9.00036-X.CrossRefPubMedGoogle Scholar
  51. 51.
    Drossman DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features, and Rome IV. Gastroenterology. 2016;150:1262.  https://doi.org/10.1053/j.gastro.2016.02.032.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • W. Harley Sobin
    • 1
  1. 1.Pleasant PrairieUSA

Personalised recommendations